Binding Mechanism and Structural Insights into the Identified Protein Target of Covid-19 with In-Vitro Effective Drug Ivermectin

enthalten in: chemRxiv.org | 2021

von Sen Gupta, P. | Biswal, S. | Panda, S. | +2

Attacking the SARS-CoV-2 Replication Machinery with the Pathogen Box’s Molecules

enthalten in: chemRxiv.org | 2021

von Osorio-Mogollon, C. | Olivos-Ramirez, G. | Otazu, K. | +7

Amodiaquine as COVID-19 Mpro Inhibitor: A Theoretical Study

enthalten in: chemRxiv.org | 2021

von Acharya, b.

A Drug Repurposing Approach to Identify Therapeutics by Screening Medicines for Malaria Ventures Exploiting SARS-CoV-2 Main Protease

enthalten in: chemRxiv.org | 2021

von Tyagi, R. | Paul, A. | Raj, V. | +2

A Biocatalytic Approach to a Key Intermediate for the Synthesis of the COVID-19 Experimental Drug Molnupiravir

enthalten in: chemRxiv.org | 2021

von Burke, A. | Birmingham, W. | Zhuo, Y. | +9

Accelerating the Discovery of the Beyond Rule of Five Compounds That Have High Affinities Toward SARS-CoV-2 Spike RBD

enthalten in: chemRxiv.org | 2021

von Abu-Saleh, A. | Yadav, A. | Poirier, R.

Ab Initio Electronic Dielectric “Constant” of Proteins: A Baseline for Electrostatic Interaction in Biomolecular Systems

enthalten in: chemRxiv.org | 2021

von Adhikari, P. | Podgornik, R. | Jawad, B. | +1

501Y.V2 Spike Protein Resists the Antibody in Atomistic Simulations

enthalten in: chemRxiv.org | 2021

von Ngo, S.

Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations

enthalten in: chemRxiv.org | 2021

von Kamikubo, Y. | Hattori, T. | Takahashi, A.

Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations

enthalten in: chemRxiv.org | 2021

von Takahashi, A. | Kamikubo, Y. | Hattori, T.